Article Details

Stoke Therapeutics, Inc. (NASDAQ:STOK) Given Average Recommendation of "Buy" by Analysts

Retrieved on: 2021-04-27 08:48:45

Tags for this article:

Click the tags to see associated articles and topics

Stoke Therapeutics, Inc. (NASDAQ:STOK) Given Average Recommendation of "Buy" by Analysts. View article details on hiswai:

Excerpt

BlackRock Inc. now owns 1,660,060 shares of the company's stock valued at $102,807,000 after acquiring an additional 423,844 shares during the ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up